D
40
-3
MHK
50
4
ADT
38
3
ALLE
35
3
CA
38
9
AMAT
41
-9
CF
41
2
PWR
41
-2
IP
53
5
MUR
39
3
DHR
41
2
PHM
37
2
PG
51
-13
EQR
54
-5
HUM
33
3
CME
48
-4
V
70
-2
ROK
44
-2
RCL
76
3
BMY
40
-3
D
40
-3
MHK
50
4
ADT
38
3
ALLE
35
3
CA
38
9
AMAT
41
-9
CF
41
2
PWR
41
-2
IP
53
5
MUR
39
3
DHR
41
2
PHM
37
2
PG
51
-13
EQR
54
-5
HUM
33
3
CME
48
-4
V
70
-2
ROK
44
-2
RCL
76
3
BMY
40
-3
Financhill
Back

Huntington Bancshares Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
65

HBAN
Huntington Bancshares

Last Price:
$16.89
Seasonality Move:
4.19%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.31
Seasonality Move:
1.75%
Buy
65
Huntington Bancshares (HBAN) is a Buy

Is Huntington Bancshares a Buy, Sell or Hold?

  • The current Huntington Bancshares [HBAN] share price is $16.73. The Score for HBAN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • HBAN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HBAN Stock Price Chart

What is Huntington Bancshares's stock price today?

  • The Huntington Bancshares share price today is $16.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HBAN is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

HBAN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 47.17 Sell
Chaikin Money Flow: -6835436 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.58 - 17.2) Sell
Bollinger Bands (100): (15.37 - 17.51) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

HBAN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.82 Sell
20-day SMA: 16.97 Sell
50-day SMA: 16.84 Sell
200-day SMA: 15.13 Buy
8-day EMA: 16.78 Sell
20-day EMA: 16.85 Sell
50-day EMA: 16.77 Sell
200-day EMA: 15.41 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Huntington Bancshares Earnings Growth & HBAN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.15 per share, and an increase next year of $0.19 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Huntington Bancshares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):